-
Mashup Score: 2Outcomes After Progression With Anti-PD-L1, Chemotherapy in mNSCLC Clinical | Docwire News - 2 month(s) ago
Patients with metastatic NSCLC who receive first-line anti-PD-L1-based IO may achieve durable disease control.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0
Age at the time of surgery and race play a role in which patients may begin smoking again following surgery for NSCLC.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
Patients with metastatic #NSCLC who receive first-line anti-PD-L1-based IO may achieve durable disease control. #lungcancer #lungcancerstoday Read More: https://t.co/Ts5GKqusSb https://t.co/121d3To1RC